Lilly cuts price on weight-loss drug Zepbound, selling it in single-dose vials

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.